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ABSTRACT 
Aim: This study aimed to compare the diffusion rate of ketoconazole in microemulsion 
containing carbopol 934 or carbopol 941 as a thickener.
Methods: Ketoconazole microemulsion was made into 7 formulas with various 
concentrations in each type of thickener, i.e 0.1%, 0.2%, 0.3%, and one formula without 
thickener. Each formula were evaluated includes organoleptic, pH measurement, viscosity, 
particle size, potential zeta, surface tension measurement, and diffusion test. 
Results: The physical properties of ketoconazole microemulsion showed liquid to gel 
form, yellow in color, specific odor, pH was in the range of 7.00-7.65, viscosity ranged 
from 2196-26037 cps, particle size was 13.6-42.2nm, zeta potential was -9.12--18.44 mV, 
and surface tension 30.7-64 dyne / cm. The diffusion kinetics obtained followed by the 
higuchi equation for the use of the two thickener, while the ketoconazole microemulsion 
without thickener (F1) followed the Korsmeyer-peppas equation with a diffusion rate of 
9.444 %/minute. The diffusion rate of ketoconazole microemulsion with carbopol 934 (F2, 
F3, F4) were 4.354, 4.638, and 4.847 %/minute, respectively. Meanwhile, the diffusion rate 
using carbopol 941 (F5, F6, F7) were 4.695, 4.742, 4.751 %/minute, respectively. 
Conclusion: It can be concluded that the diffusion rate (sig ˂ 0,05,) of ketoconazole in 
microemulsion containing carbopol 941 was faster than diffusion rate of microemulsion 
containing carbopol 934 at the same concentration in the microemulsion system. 
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INTRODUCTION 
Previous studies have shown that tween 80 can form ketoconazole microemulsion with 
Virgin Coconut Oil (VCO) at a concentration of 55% to produce the most stable 
microemulsion with a diffusion yield of 61.07% at 60 minutes [1]. However, the use of tween 
80 above 50% can cause skin irritation [2]. The use of 35% tween 80 can produce 
ketoconazole microemulsion but does not show stability during 8 weeks of storage due to the 
low viscosity of the microemulsion [1]. Low viscosity of microemulsions can also prevent 
clinical applications due to unpleasant use and make preparations less attractive [3]. Addition 
of thickener can increase the viscosity of microemulsions. Increased viscosity can slow 
particle movement resulting in slower particle deposition or phase separation and 
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microemulsions becoming more stable. However, increasing viscosity can reduce the 
diffusion coefficient so that it affects the rate of diffusion of the active substance [4]. 
The thickener that can be used is carbopol which is used in most liquid and semisolid 
preparations, stable at low temperatures and antimicrobial [5]. There are various types of 
carbopol including carbopol 934 and carbopol 941. Carbopol 934 is acrylic acid which has 
crosslinking with sucrose allyl ether, whereas carbopol 941 is acrylic acid which has a 
crosslinked with pentaerithritol allyl ether [6].  
 This study aims to compare the rate of diffusion of ketoconazole in microemulsion with 
virgin coconut oil using carbopol 934 and carbopol 941 as thickener. 
 
MATERIALS AND METHODS 
 
Materials 
The materials used were Ketoconazole (PT. Kalbe Farma), VCO (CV. Herba Bagoes), Tween 
80 (PT. KAO), Sorbitol, Nipagin, Nipasol (PT. Kimia Farma), Carbopol 934 (Shrec 
Chemical), Carbopol 941 ( Zhongtang), triethanolamine, and Aqua destillata. 
 
Ketoconazol Microemulsion  
 
Table 1: Ketoconazol Microemulsion [1] 
 
 
 
 
 
 
 
 
 
 
 
Nipagin, nipasol, and tween 80 are dissolved in aqua fervida (800C ± 20C), then mixed until 
homogeneous, then the temperature is reduced to 400C ± 20C (water phase). Ketoconazole is 
dissolved in VCO, then stirred using a magnetic stirrer at 500 rpm and a temperature of 400C 
± 20C for 15 minutes (oil phase). The oil phase is added to the water phase gradually while 
stirring using a magnetic stirrer at 500 rpm and a temperature of 400C ± 20C for 15 minutes. 
Sorbitol is added drop by drop while stirring using a magnetic stirrer at 500 rpm and 400C ± 
20C. Stirring was continued for 15 minutes [1]. 
The ratio between microemulsion and thickener used was 90:10 [7]. Ketoconazole 
microemulsion with the addition of thickener (Table 2) is made by dispersing carbopol in 
distilled water, then allowed to stand for 24 hours, 50% TEA solution is added dropwise until 
the pH dispersion of carbopol reaches pH 5.5, then the carbopol dispersion is slowly added to 
the ketoconazole microemulsion, while stirred using a magnetic stirrer at 300 rpm for 15 
minutes at room temperature [7]. After 24 hours, preparations were evaluated including 
organoleptic, pH, viscosity, particle size, zeta potential, drug content and diffusion test. 
 
 
 
 
 
Formula   (%) 
Ketoconazol 0.4 
VCO 5 
Tween 80 35 
Sorbitol 10 
Nipagin 0.18 
Nipasol 0.02 
Aqua Destillata qs to 100 
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Tabel 2: Formulas of Ketoconazol Microemulsion with Thickener 
 
 Formula 
F1 F2 F3 F4 F5 F6 F7 
Ketoconazol 
Microemulsion  
100ml 90ml 90ml 90ml 90ml 90ml 90ml 
Carbopol 934 (%) - 0.1 0.2 0.3 - - - 
Carbopol 941 (%) - - - - 0.1 0.2 0.3 
TEA 50% solution - 0.37ml 0.89ml 1.35ml 0.57ml 1.34ml 1.67ml 
Aqua Destillata qs to -  100ml  100ml  100ml  100ml  100ml  100ml 
 
 
Evaluation of Ketoconazol Microemulsion 
Viscosity measurement is done using Brookfield viscometer (LV type) using spindle No. 63 
with 30 rpm for F1, F2, F3, F5, F6, F7, and Spindle No. 64 with 20 rpm for F4. 
Microemulsion is inserted into a beaker glass until it reaches a volume of 250 ml, then attach 
the spindle to the specified limit. Surface tension measurements were carried out by the Du 
Nouy ring method. The force was determined by measuring the turning angle of the circular 
wire used to pull out the platinum-iridium ring from the effect of interfacial forces. 
The particle size and zeta potential were measured using Nano Particle Size Analyzer 
(Beckman). The sample is inserted into the flow cell by using a syringe, then the flow cell is 
inserted into the device. The instrument will measure the sample for 9 minutes, after that it 
gives the results of particle size, potential zeta, and PD index samples.  
Determination of the sample content was carried out using sample that an equivalent active 
ingredient of 4.14 mg and then added methanol to 10 ml then centrifuged at a 4000 rpm for 
45 minutes, then 0.5 ml of supernatant put into a 10 ml volumetric flask, then add methanol 
to the boundary mark. Measure absorbance using a UV-Vis spectrophotometer (Shimadzu) at 
a wavelength of 243 nm [8]. 
Diffusion test is carried out using a modified flow-through method from Franz diffusion cells, 
at 37 ± 1oC with receptor fluid 330 ml solution of 30% methanol phosphate buffer pH 7.4, 
and using 1 gram sample that placed on a membrane. The test was carried out for 8 hours, the 
samples were taken 10.0 ml and each take was carried out by replacing the new receptor fluid 
at the same volume. Sampling was carried out at minutes 5, 10, 15, 30, 45, 60, 80, 100, 120, 
150, 180, 210, 240, 300, 360, 420, 480. The absorbance of sample was measured at a 
wavelength of 225.8 nm using UV-Vis Spectrophotometer [1,8]. 
 
 
RESULTS AND DISCUSSION 
 
Results of Organoleptic Test 
The results of organoleptic observation can be seen in Table 3. The form of ketoconazole 
microemulsion preparations becomes thicker due increases of the carbopol concentration.  
 
Table 3: Organoleptic of  Ketoconazol Microemulsion 
 
Formula Appearance Color 
F1 Solution  Clear Yellow 
F2 Viscous solution Clear Yellow 
F3 Viscous solution Cloudy yellow 
F4 Gel Cloudy yellow 
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F5 Viscous solution Clear Yellow 
F6 Gel Clear Yellow 
F7 Gel Cloudy yellow 
 
 
Results of pH Value 
The results of pH measurements indicate that pH is in the range of 7.00-7.65 which is close to 
the normal skin pH range of 5 - 6.5 [9]. All formulas can meet the criteria of good and safe 
topical preparations. 
Measurement of the pH of the microemulsion of ketoconazole before adding carbopol is 7.5-
7.8. The thickness of carbopol is affected by pH. Base addition (TEA) will break the carboxyl 
group in carbopol and increase the negative charge which causes the carboxyl group to be 
ionized so that an electrostatic repulsion occurs. The repulsion force between ionized groups 
causes hydrogen bonds in the carboxyl group to stretch so that an increase in viscosity 
[10,11]. 
 
Results of Viscosity 
Viscosity measurement results can be seen in Figure 1. The viscosity value of F4 using 
carbopol 934 is higher than the viscosity of F7 using carbopol 941 with the same 
concentration. 
 
 
Figure 1: Results of Viscosity 
 
The carbopol 941 dispersion is more acidic than the carbopol 934 dispersion. This is due to 
the crosslinking of carbopol 941 that is the pentaerithritol allyl ether is more acidic than the 
sucrose allyl ether which is the crosslinking of carbopol 941 (USP Convention 2007) [6]. 
These structural differences that affect the ability to stretch the polymer chain to trap water 
thus affecting the viscosity value. 
Increased viscosity is proportional to the increase in the concentration of polymer used [12]. 
High viscosity will provide stability in the preparation because it will make the disperse 
medium become more rigid (stiff) and minimize the movement of dispersed phase droplets so 
that the possibility of coalescence can be prevented [13]. Increased viscosity will also 
increase retention time at the application site [14]. 
 
 
0
5000
10000
15000
20000
25000
30000
F1 F2 F3 F4 F5 F6 F7
2196 3730 
5851 
26037 
3258 
8558 
9958 
V
is
co
si
ty
 ( 
cp
s)
 
Formula 
Rahmah Elfiyani et al ISPST 2018 ISSN: 0975-1459
JPSR-November(S)2018 194
Results of Particle Size, Polydispersity Index (PdI), and Zetta Potential  
 
Table 4: Particle size, Zetta Potential and PdI of  Ketoconazol Microemulsion 
 
Formula Zetta Potential * Particle size (nm)* PdI* 
F1 -9.12 ± 0.31 13.6 ± 1.0 0.241 ± 0.06 
F2 -9.97 ± 2.47 18.4 ± 1.2 0.571 ± 0.00 
F3 -6.17 ± 0.91 24.7 ± 0.1 0.571 ± 0.00 
F4 -9.53 ± 0.98 33.6 ± 1.7 0.571 ± 0.00 
F5 -9.69 ± 2.20 28.8 ± 0.1 0.571 ± 0.00 
F6 -13.01 ± 1.15 37.6 ± 0.2 0.571 ± 0.00 
F7 -18.44 ± 5.25 42.2 ± 0.6 0.571 ± 0.00 
  *n = 3 
 
Polydispersity index value (PdI) provides information about droplet size uniformity of an 
emulsion [15]. From the measurement results obtained PdI F1 is 0.271 and PdI F2-F7 is 
0.571. The addition of thickener can change the microstructure of the microemulsion which 
results in larger dispersion particles [16]. The enlarged particle size causes the viscosity and 
specific gravity to increase, but the particle size of the seven formulas is still included in the 
particle size requirement for microemulsion that is 10-100 nm [17]. 
The potential zeta indicates the charge of the particle in a specific medium. The stability of 
nanodispersion during storage can be predicted from potential zeta values. The potential zeta 
value of F1 is -9.12 while F2-F7 is in the range of -9.97 to -18.44. The addition of thickener 
can increase the stability of the microemulsion because microemulsion globules are trapped 
in the thickener base. When the globules are trapped in the thickener base, it will be difficult 
for the globule to join other globules because the outer phase of the microemulsion is a thick 
medium. This measure is the basis for the stability of an emulsion to the rate of creaming [4]. 
 
Results of Surface Tension 
Surface tension was measured by Tensiometer Du Nuoy. The surface tension of the 
preparation is between 30.7-64 dyne / cm. The lowest surface tension is found in F1 which is 
a microemulsion without the addition of thickener. Linear surface tension value with 
viscosity measurement. This is because a larger force is needed to make the lamella torn on a 
thicker preparation. 
 
Results of Ketoconazole Content 
Determination of ketoconazole content in the preparation was carried out using a UV-Vis 
spectrophotometer at a wavelength of 243.00 nm in the medium of methanol. From the 
calibration curve, the regression equation y = 0.0322 x + 1.4762.10-3 with a correlation 
coefficient of 0.9999. The results of determining the ketoconazole content obtained were 
88,0453-91,3459%. 
 
Results of Diffusion Rate 
The diffusion test used medium 30% methanol phosphate buffer pH 7.4. The ketoconazole 
calibration curve in 30% methanol phosphate buffer pH 7.4 at a wavelength of 225.80 nm 
produces a regression equation = 0.0384 x + 2.4367.10-4 with a correlation coefficient of 
0.9999. The amount of diffuse ketoconazole can be seen in Figure 2 and the release kinetics 
can be seen in Table 5. 
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. 
Figure 2: Diffusion profile of Ketoconazol from Microemulsion 
 
From the diffusion profile it is seen that at percent diffused ketoconazole microemulsion with 
the addition of thickener is lower than the diffused percent microemulsion without thickener. 
In addition, the peak time at each increase in the concentration of carbopol becomes slower. 
This happens because the addition of thickener to the microemulsion can inhibit drug release 
[18]. 
 
Table 5: Diffusion Kinetics of Ketoconazole Microemulsion 
 
*n = 3 
 
The microemulsion without the addition of thickener (F1) follows the Korsmeyer-Peppas 
kinetics. In the Korsmeyer-Peppas equation the release mechanism depends on the value of 
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Time (minute) 
F1
F2
F3
F4
F5
F6
F7
Formula Orde 0 Orde 1 Higuchi Korsmeyer-peppas 
 r k r k r k r k n 
F1 0.883 ± 0.036 
0.177 ± 
0.002 
0.806 ± 
0.056 
0.003 ± 
0.000 
0.945 ± 
0.021 
4.465 ± 
0.074 
0.947 ± 
0.043 
9.474 ± 
1.438 
0.380 ± 
0.031 
F2 0.903 ± 0.040 
0.176 ± 
0.003 
0.845 ± 
0.041 
0.003 ± 
0.000 
0.928 ± 
0.027 
4.354 ± 
0.135 
0.924 ± 
0.027 
6.529 ± 
1.075  
F3 0.948 ± 0.010 
0.187 ± 
0.006 
0.839 ± 
0.020 
0.004 ± 
0.001 
0.968 ± 
0.014 
4.638 ± 
0.143 
0.963 ± 
0.009 
4.757 ± 
1.060  
F4 0.933 ± 0.023 
0.195 ± 
0.003 
0.801 ± 
0.022 
0.004 ± 
0.000 
0.973 ± 
0.005 
4.847 ± 
0.016 
0.972 ± 
0.004 
3.613 ± 
0.427  
F5 0.910 ± 0.023 
0.187 ± 
0.003 
0.795 ± 
0.028 
0.003 ± 
0.000 
0.974 ± 
0.002 
4.695 ± 
0.039 
0.971 ± 
0.008 
6.611 ±  
1.045  
F6 0.924 ± 0.036 
0.190 ± 
0.005 
0.807 ± 
0.059 
0.004 ± 
0.001 
0.968 ± 
0.004 
4.742 ± 
0.188 
0.963 ± 
0.010 
4.348 ± 
1.052  
F7 0.930 ± 0.016 
0.190 ± 
0.003 
0.792 ± 
0.020 
0.004 ± 
0.000 
0.981 ± 
0.002 
4.751 ± 
0.033 
0.978 ± 
0.003 
4.032 ±  
0.666  
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'n'. In Table 5 can be seen the value of ‘n 'of the preparation is 0.38. A value of n less than 
0.45 indicates the mechanism of release of ketoconazole is the Fickian diffusion mechanism 
[19]. Drug release following Fickian diffusion means following Fick I law [20]. Whereas for 
microemulsions with the addition of thickener, F2-F6 follows Higuchi's kinetics. Preparations 
with release kinetics follow Higuchi's kinetics, their release can occur because the amount of 
drug in the carrier is greater than the number of drugs in the diffusion medium so that 
ketoconazole can diffuse from high concentrated areas to low concentrated areas after the 
diffusion medium penetrates the membrane and dissolves the drug. In addition, small drug 
particles can facilitate drug particles to penetrate the membrane [21]. 
The value of the diffusion rate constant (k) on the microemulsion with the addition of 
thickener has decreased compared to the microemulsion without thickener. This is according 
to the Stokes-Einstein law which states that viscosity is inversely proportional to diffusion. 
The thicker the preparation, the harder it will be to release the drug from the carrier. So that 
the diffusion rate constant is lower [4]. But the diffusion rate constant (k) increases as the 
concentration of carbopol increases. This can happen because carbomer exhibits very high 
adhesive bond strength in contact with tissues, enhancing the penetration of drugs [22]. 
The results of statistical tests on diffusion rate constants using Non Parametric analysis 
produced sig values < 0.05, then H0 was rejected, meaning that the average diffusion rate 
constant value of ketoconazole microemulsion without thickener was different from the 
diffusion rate constant of ketoconazole microemulsion with the addition of thickener. While 
parametric analysis is performed on the use of thickener types between carbomer 934 and 
carbomer 941 did not show a significant difference (sig value > 0.05) on the diffusion rate 
constant. Statistical analysis also showed that there is an interaction between the type of 
thickener and the concentration of thickener used to produce a significant difference in the 
diffusion rate constant (sig value < 0.05). based on tukey HSD, it can be seen that significant 
differences in the diffusion rate occur when using a thickener with a concentration of 0.1 and 
0.3% (sig value < 0.05) 
CONCLUSION  
It can be concluded that the use of carbopol 941 results in faster diffusion rate of 
ketoconazole compared to carbopol 934 in microemulsion systems. 
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